2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Metastatic NSCLC w/o Actionable Mutations: Chemo-Free Option With Nivo + Ipi, Nivo + Ipi + Chemo Safe and Tolerable & Data on Novel Anti-TIGIT Agent Tiragolumab + Atezo
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jason Porter
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jason Porter
Comments 0
Login to view comments.
Click here to Login
